Bayer to Consider Selling Animal Health Division

April 13, 2016

Bayer will consider selling its animal health unit if it continues to struggle, the company’s incoming chief executive said.

“Animal Health is a business that we have been trying for many years to strengthen strategically—that is to say, inorganically; that is still our goal,” said strategy chief Werner Baumann, who is to take over as CEO on May 1.

Baumann declined to comment on how much longer Bayer would continue looking for takeover targets for the veterinary drugs unit.

“Should we not succeed at that in the end, we will have to ask the strategic question—as is the case with all our businesses—are these businesses well placed with us as best owner or can these businesses perhaps progress better in a different environment, with different access to resources,” Baumann said.

Bayer is on track to become a second-tier player in animal health behind four market leaders. This is the result of major consolidation moves in the sector.

Share This Story On:

Digital Guide

CBD Trends

This digital guide provides valuable information on the subject of CBD, including content on dosage and the importance of being fully transparent about the product’s origin

Dog & Cat Needs

With dogs and cats being members of the family, there's vital information to know in order to serve their pet parents.

Pet Nutrition

Discover how science, technology and pet owning lifestyles are changing the industry.

Pet Parenting

This digital guide dives into the human-animal bond, and the roles that pet parents play in the development of their companion animals.

Enews Subscribe

Subscribe To Pet Age
Sign up for the weekly e-newsletter, print magazine and more. Sign Up